757 Comparison of Nephrotoxicity in Outpatient Parenteral Antimicrobial Therapy (OPAT) Patients Receiving Beta-lactams or Vancomycin

por Streifel, Amber, Felder, Kimberly, Taylor, Jerusha, Barnes, Penelope
Publicado 2014

1004. Dalbavancin Use and Associated Cost-Savings: An Update

por Streifel, Amber C, Sikka, Monica K, Lewis, James S
Publicado 2022

1028. Dalbavancin Use in Complicated Infections and-associated Cost-Savings

por Streifel, Amber C, Sikka, Monica, Sikka, Monica, Lewis, James
Publicado 2019

1229. Outpatient Penicillin and Sulfonamide Antibiotic Allergy E-Consult Service in Prospective Solid Organ Transplant Recipients

por Bair, Amanda M, Joshi, Shyam, Anstey, Karen, Streifel, Amber C, Ham, YoungYoon
Publicado 2023

1268. Dalbavancin for the Treatment of Infections due to Staphylococcus aureus

por Streifel, Amber C, Sukerman, Ellie, Sikka, Monica, Makadia, Jina, Lewis, James, Luke, Strnad
Publicado 2020

Description and outcomes of patients with substance use disorder with serious bacterial infections who had a multidisciplinary care conference

por Conte, Michael, Schneider, Brent, Varley, Cara D., Streifel, Amber C., Sikka, Monica K.
Publicado 2022

Screening for co-infections in patients with substance use disorders and severe bacterial infections

por Varley, Cara D., Conte, Michael, Streifel, Amber C., Winders, Bradie, Sikka, Monica K.
Publicado 2022

188. Outcomes After Implementing the OPTIONS-DC Multidisciplinary Care Conference for Patients with Substance Use Disorders and Severe Bacterial Infections

por Schneider, Brenton J, Streifel, Amber C, Varley, Cara D, Conte, Michael, Sikka, Monica K
Publicado 2021

The challenge of antibiotic selection in prosthetic joint infections due to Corynebacterium striatum: a case report

por Streifel, Amber C., Varley, Cara D., Ham, YoungYoon, Sikka, Monica K., Lewis, James S.
Publicado 2022

625. The Hidden Cost of Dalbavancin: OPAT-RN Time Spent on Coordination for Patients with Substance Use Disorder

por Douglass, Alyse, Mayer, Heather, Young, Kathleen, Streifel, Amber C, Makadia, Jina, Lewis, James, Sikka, Monica K
Publicado 2021

1801. About Damn Time: HAV, HBV, and Tetanus Screening and Vaccination during Hospitalization in Persons who Use Drugs

por Streifel, Amber C, Sarti, Jose E Rivera, Sikka, Monica K, Conte, Michael, Winders, Bradie, Varley, Cara D
Publicado 2023

597. Comparison of Vancomycin and Daptomycin Complications and Interventions in Outpatient Parenteral Antimicrobial Therapy

por Nakrani, Monark, Yu, Diana, Sikka, Monica, Lewis, James, Douglass, Alyse, Mayer, Heather, Young, Kathleen, Streifel, Amber C
Publicado 2020

122. Dalbavancin Use in Patients with Substance Use Disorders

por Streifel, Amber C, Makadia, Jina, Luke, Strnad, Douglass, Alyse, Mayer, Heather, Young, Kathleen, Lewis, James, Sukerman, Ellie, Sikka, Monica
Publicado 2020

1762. A Review of Antibiotic Outcomes Data Utilizing the Multidisciplinary OPTIONS-DC Conference for PWUD

por Douglass, Alyse H, Mayer, Heather, Young, Kathleen, Streifel, Amber C, Franklin, Heather, Strnad, Luke, Makadia, Jina T, Sikka, Monica K
Publicado 2022

The hidden cost of dalbavancin: OPAT RN time required in coordination for persons who use drugs

por Douglass, Alyse H., Mayer, Heather, Young, Kathleen, Sikka, Monica K., Strnad, Luke, Makadia, Jina, Sukerman, Ellie, Lewis, James S., Streifel, Amber C.
Publicado 2023

2499. What Are We Waiting for? Chronic Hepatitis C Treatment Initiation During Inpatient Admission

por Ham, YoungYoon, Ryu, HaYoung, Williams, Carissa, Babiarz, Jane, Varley, Cara D, Streifel, Amber C, Maier, Marissa, Conte, Michael, Govindan, Sujeet
Publicado 2023